Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study

Guillermo Garcia‐Manero, Aaron D. Goldberg, Eric S. Winer, Jessica K. Altman, Amir T. Fathi, Olatoyosi Odenike, Gail J. Roboz, Kendra Sweet, Crystal Miller, Anders Wennborg, Denice Hickman, Rashmi Kanagal‐Shamanna, Hagop M. Kantarjian, Jeffrey E. Lancet, Rami S. Komrokji, Eyal C. Attar, David A. Sallman